Therefore, we suggest that impaired Ca2+ homeostasis in the brain may play a role in the neurological complications of diabetes, as treatment with a Ca2+ channel blocker improves Ca2+-dependent synaptic plasticity in the hippocampus of diabetic patients [26]. This evidence concerns the gene CA2 and diabetes mellitus.